Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Chinese Tech Stocks Slide as U.S.-China Trade Talks Stall

by Team Lumida
May 30, 2025
in Markets
Reading Time: 4 mins read
A A
0
Chinese Stock Surge: A Hedge Fund Headache?
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Chinese tech stocks fell sharply, with Alibaba down 4.2%, BYD dropping 3.8%, and Baidu losing 3.9%, as the Hang Seng Tech Index declined 2.7%.
  • U.S. Treasury Secretary Scott Bessent described U.S.-China trade talks as “a bit stalled,” dampening hopes for a near-term agreement.
  • Analysts see little chance of a breakthrough, citing persistent trade tensions, lack of mutual trust, and challenges in addressing issues like the trade deficit and high-tech export restrictions.
  • Markets remain fatigued by ongoing uncertainty, with investors showing muted reactions to recent developments, including a U.S. court ruling on Trump’s tariffs.

What Happened?

Chinese tech stocks declined on Friday amid renewed pessimism about the prospects for a U.S.-China trade deal. The Hang Seng Tech Index dropped 2.7%, led by major players like Alibaba (-4.2%), BYD (-3.8%), and Baidu (-3.9%).

The selloff followed comments from U.S. Treasury Secretary Scott Bessent, who described trade talks as “a bit stalled” and suggested that a high-level meeting between President Trump and Chinese President Xi Jinping would only occur after significant progress.

The market reaction also reflects lingering uncertainty after a U.S. trade court ruling blocked Trump’s tariffs, a decision that was quickly appealed. Analysts believe the two sides remain far apart on key issues, including the U.S. trade deficit, restrictions on high-tech exports, and broader geopolitical tensions.


Why It Matters?

The stalled trade talks highlight the ongoing challenges in resolving U.S.-China trade tensions, which have weighed on global markets and investor sentiment. For Chinese tech companies, the uncertainty adds to existing pressures, including U.S. restrictions on advanced chip exports and concerns over regulatory scrutiny.

The lack of progress in negotiations underscores the difficulty of addressing structural issues, such as China’s ability to buy more U.S. goods to reduce the trade deficit. Analysts warn that the prolonged uncertainty could lead to years of negotiations, further straining relations between the world’s two largest economies.

For investors, the constant whiplash over tariffs and trade headlines is creating fatigue, with markets becoming less sensitive to incremental developments. This could limit the upside for Chinese equities in the near term, particularly in the tech sector.


What’s Next?

While a high-level meeting between Trump and Xi could provide a breakthrough, analysts believe such talks are unlikely without significant progress in negotiations. Smaller-scale cooperation, such as addressing the fentanyl issue, may offer a path to extending talks and easing tensions.

Investors will continue to monitor developments in U.S.-China relations, including any updates on tariffs, trade agreements, and regulatory actions. For now, the outlook for Chinese tech stocks remains uncertain, with market sentiment heavily influenced by geopolitical risks and trade policy.

Source
Tags: China
Previous Post

Microdosing Weight-Loss Drugs Like Ozempic Gains Popularity Despite Safety Concerns

Next Post

EssilorLuxottica Acquires AI-Driven Ophthalmology Platform Optegra to Expand Medical Technology Portfolio

Recommended For You

Mars to Invest $2 Billion in U.S. Manufacturing Over Next 18 Months

by Team Lumida
13 hours ago
Mars to Invest $2 Billion in U.S. Manufacturing Over Next 18 Months

Key Takeaways: Powered by lumidawealth.com New Investment: Mars plans to invest an additional $2 billion in its U.S. factories over the next 18 months, building on $6 billion invested...

Read more

Apple to Close Retail Store in China for the First Time Amid Changing Market Conditions

by Team Lumida
18 hours ago
apple logo on blue surface

Key Takeaways: Powered by lumidawealth.com First Store Closure in China: Apple will shut its Parkland Mall store in Dalian City on August 9, marking its first retail store closure...

Read more

Samsung Secures $16.5 Billion Tesla Chip Deal to Revive Foundry Business

by Team Lumida
2 days ago
blue coupe parked beside white wall

Key Takeaways: Powered by lumidawealth.com Massive Contract Win: Samsung Electronics secured a $16.5 billion semiconductor manufacturing deal with Tesla running through 2033, providing a major boost to its struggling...

Read more

LVMH in Talks to Sell Marc Jacobs Brand for Around $1 Billion

by Team Lumida
4 days ago
LVMH in Talks to Sell Marc Jacobs Brand for Around $1 Billion

Key Takeaways: Powered by lumidawealth.com Billion-Dollar Sale: LVMH is in discussions to sell the Marc Jacobs fashion brand for approximately $1 billion, marking another strategic divestiture by the luxury...

Read more

Morgan Stanley Becomes First U.S. Firm to Issue Panda Bond in China

by Team Lumida
5 days ago
Morgan Stanley Q2 2024 Earnings Summary

Key Takeaways: Powered by lumidawealth.com Historic First: Morgan Stanley has issued a 2 billion yuan $279 million) five-year panda bond, marking the first time a U.S. company has tapped...

Read more

T-Mobile Tops Rivals With Subscriber Gains, Raises Outlook

by Team Lumida
6 days ago
T-Mobile Tops Rivals With Subscriber Gains, Raises Outlook

Key Takeaways: Powered by lumidawealth.com Subscriber Growth Beats Expectations: T-Mobile added 830,000 net postpaid wireless phone connections in Q2 (up 7% YoY) and 454,000 net broadband connections (up 12%),...

Read more

Chinese Hackers Exploit Microsoft SharePoint Flaws, Breaching U.S. Nuclear Agency and Dozens More

by Team Lumida
7 days ago
China’s Bold Economic Moves: What You Need to Know Now

Key Takeaways: Powered by lumidawealth.com Widespread Breach: Chinese state-sponsored hackers exploited vulnerabilities in Microsoft SharePoint, breaching over 100 servers across 60 organizations—including the U.S. National Nuclear Security Administration, Education...

Read more

Goldman Sachs: Trump’s Tariffs to Lift Baseline Rate to 15%, Fueling Inflation and Slowing Growth

by Team Lumida
7 days ago
Goldman Predicts US Job Market Shift: Stands by Two Rate Cut Forecast

Key Takeaways: Powered by lumidawealth.com Tariff Hike Expected: Goldman Sachs forecasts the U.S. baseline “reciprocal” tariff rate will rise from 10% to 15%, with a 50% levy on copper...

Read more

Morgan Stanley Faces Expanded Scrutiny Over Client Vetting and Anti-Money-Laundering Controls

by Team Lumida
7 days ago
Morgan Stanley Faces Expanded Scrutiny Over Client Vetting and Anti-Money-Laundering Controls

Key Takeaways: Powered by lumidawealth.com Finra Probe Widens: Wall Street’s self-regulator, Finra, is investigating whether Morgan Stanley properly screened wealth-management and trading clients for money-laundering risks from October 2021...

Read more

AstraZeneca to Invest $50 Billion in U.S. Manufacturing and R&D by 2030 Amid Tariff Threats

by Team Lumida
1 week ago
AstraZeneca to Invest $50 Billion in U.S. Manufacturing and R&D by 2030 Amid Tariff Threats

Key Takeaways: Powered by lumidawealth.com Major U.S. Commitment: AstraZeneca will invest $50 billion in the U.S. by 2030*, including a new manufacturing center in Virginia focused on chronic disease...

Read more
Next Post
EssilorLuxottica Acquires AI-Driven Ophthalmology Platform Optegra to Expand Medical Technology Portfolio

EssilorLuxottica Acquires AI-Driven Ophthalmology Platform Optegra to Expand Medical Technology Portfolio

Will September’s Fed Rate Cuts Surprise Investors? Here’s What Deutsche Bank Predicts

Trump Pressures Fed Chair Powell to Cut Interest Rates, Citing Economic Disadvantage

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

black and silver letter y

Chevrolet Silverado Faces Major Threat from Trump’s Tariff Policies

March 3, 2025
man wearing academic gown

Elite Colleges Too Expensive for Middle-Class Families, Even at $300,000 Income

April 27, 2025
red and black metal tower during sunset

The World’s Largest Oil Company Believes Petrol Engines Will Outlast Electric Cars

July 9, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018